Influence of transfusion-transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis C
H. Hagiwara et al., Influence of transfusion-transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis C, J VIRAL HEP, 6(6), 1999, pp. 463-469
Recently, the genome of a novel DNA virus, transfusion-transmitted virus (T
TV), was cloned from the plasma of a blood donor who had an elevated aminot
ransferase level but no serological markers of known hepatitis viruses. In
this study, we investigated the influence of TTV infection on the clinical
features and response to interferon (IFN) therapy in patients with chronic
hepatitis C. We studied 247 patients who had received a 16- or a 24-week co
urse of IFN-alpha therapy. The serum of these patients was analysed for TTV
DNA using a hemi-nested polymerase chain reaction and TTV was detected in
114 patients (46%). No significant differences were found with respect to c
linical features (gender, age, liver-related biochemical tests, hepatitis C
virus (HCV) genotype and serum HCV RNA levels) between the patients who we
re positive for TTV DNA and those who were negative for TTV DNA. The fibros
is score was higher in TTV-positive patients (2.1 +/- 1.1) than in TTV-nega
tive patients (1.7 +/- 1.1, P = 0.023). The biochemical sustained-response
rate was 25% in TTV-positive patients and 25% in TTV-negative patients (not
significant). A sustained HCV clearance rate was achieved in 26% of TTV-po
sitive patients and in 22% of TTV-negative patients (not significant). TTV
DNA clearance after IFN therapy was observed in 36 of 69 patients (52%) for
whom stored serum samples were available. The disappearance of TTV DNA had
no effect on the biochemical response to IFN therapy. In conclusion, TTV c
o-infection is frequently observed in Japanese patients with chronic hepati
tis C. In chronic hepatitis C, TTV does not modify the clinical features or
the response to IFN.